FACTORS ASSOCIATED WITH SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS IN PATIENTS TREATED WITH ANTI-TUMOUR NECROSIS FACTOR: A SYSTEMATIC REVIEW

被引:0
作者
Hamann, Philip [1 ]
Holland, Richard [2 ,3 ]
Hyrich, Kimme [4 ]
Pauling, John [2 ,3 ]
Shaddick, Gavin [5 ]
Nightingale, Alison [1 ]
McHugh, Neil [1 ]
机构
[1] Univ Bath, Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[2] Royal Natl Hosp Rheumat Dis, Rheumatol, Upper Borough Walls, Bath BA1 1RL, Avon, England
[3] Royal United Hosp, Bath BA1 3NG, Avon, England
[4] Univ Manchester, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
[5] Univ Bath, Math Sci, Bath BA2 7AY, Avon, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
093
引用
收藏
页码:100 / 100
页数:1
相关论文
共 50 条
  • [41] Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
    Cavazzana, I.
    Franceschini, F.
    Danieli, E.
    Airo, P.
    Cattaneo, R.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2005, 7 : S13 - S13
  • [42] Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
    I Cavazzana
    F Franceschini
    E Danieli
    P Airò
    R Cattaneo
    [J]. Arthritis Research & Therapy, 7
  • [43] Severe glandular tularemia in a patient treated with anti-tumour necrosis factor for psoriatic arthritis
    Calin, Ruxandra
    Caumes, Eric
    Reibel, Florence
    Mohamed, Anzime Ali
    Brossier, Florence
    Foltz, Violaine
    Boussouar, Samia
    Fautrel, Bruno
    Maurin, Max
    Katlama, Christine
    Pourcher, Valerie
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 60 : 1 - 3
  • [44] The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-α therapy
    Bingham, SJ
    Buch, MH
    Tennant, A
    Emery, P
    [J]. RHEUMATOLOGY, 2004, 43 (03) : 364 - 368
  • [45] Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment
    ten Klooster, Peter M.
    Veehof, Martine M.
    Taal, Erik
    van Riel, Piet L. C. M.
    de Laar, Mart A. F. J. van
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (11) : 1485 - 1490
  • [46] Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis
    Iagnocco, Annamaria
    Finucci, Annacarla
    Ceccarelli, Fulvia
    Perricone, Carlo
    Iorgoveanu, Vasilia
    Valesini, Guido
    [J]. RHEUMATOLOGY, 2015, 54 (10) : 1890 - 1896
  • [47] LACK OF REPLICATION OF PTPRC GENE AS A PREDICTOR OF RESPONSE TO ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Canhao, Helena
    Rodrigues, Ana
    Santos, Maria Jose
    Carmona-Fernandes, Diana
    Costa, Jose
    Santos, Helena
    Branco, Jaime
    Plenge, Robert
    Solomon, Daniel
    Armas, Jacome
    Silva, Jose Antonio
    Fonseca, Joao Eurico
    Karlson, Elizabeth
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : A53 - A53
  • [48] Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
    AI Catrina
    S Ernestam
    E af Klint
    L Klareskog
    AK Ulfgren
    [J]. Arthritis Res Ther, 6
  • [49] Association of baseline cytokine levels with anti-tumour necrosis factor treatment response in rheumatoid arthritis
    Gibson, David S.
    McGeough, Cathy M.
    Slevin, Mary M.
    Wright, Gary
    Gardiner, Philip
    Murray, Helena A.
    Latten, Mark J.
    Crockard, Martin A.
    Lamont, John V.
    Bjourson, Anthony J.
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (01)
  • [50] What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
    Feldmann, M
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 111 (04) : 362 - 365